ACTRN12606000363583
Recruiting
N/A
A randomised controlled trial to evaluate the effect of Temgesic (0.2mg) in combination with exposure therapy for the treatment of social phobia to improve the severity of social phobia symptoms.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Social Phobia
- Sponsor
- niversity of New South Wales
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults with a primary diagnosis of social phobia.
Exclusion Criteria
- •Significant liver and kidney impairment, imparied respiratory function, head injury, substance abuse and dependence. Participants must not drink alcohol, caffeine or grapefruit juice on the day of drug administration.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A randomised controlled trial to evaluate the effects of oral steroid therapy on the development of pulmonary fibrosis in patients with sarcoidosisRespiratory diseaseRespiratoryISRCTN11814269Medical Research Council (MRC) (UK)
Recruiting
N/A
Investigating the effect of optimising amino acid intake on obesity rates in individuals aged 65-80 years.ObesityDiet and Nutrition - ObesityACTRN12621000402842The University of Sydney110
Recruiting
N/A
sing an app for suicide prevention amongst young Indigenous people: A randomised controlled trialACTRN12614000686606Black Dog Institute / University of New South Wales570
Completed
N/A
Cognitive Behaviour Therapy of Acute Stress DisorderACTRN12607000391471niversity of New South Wales90
Completed
N/A
A randomised controlled trial to evaluate task-related exercise classes for older people with impaired mobilityOlder people with impaired mobilityOther -ACTRN12605000346673Prince of Wales Medical Research Institute160